Characterisation of Platelet Releasate Proteome in Relapsing‐Remitting Multiple Sclerosis Reveals Dysregulation of Inflammatory Signalling and Extracellular Vesicle Dynamics
PROTEOMICS – Clinical Applications · 2025
DOI: 10.1002/prca.202400019 ↗Kurz gefasst
Fachartikel in der Zeitschrift PROTEOMICS – Clinical Applications, 2025. Verfasst von Martin Parsons und 11 weiteren Autor:innen. Beteiligte Einrichtung: SPHERE Research Group, Conway Institute, University College Dublin, Dublin, Ireland. Hauptthemen laut MEDLINE: Multiple Sclerosis, Relapsing-Remitting, Extracellular Vesicles, Blood Platelets, Proteome. Die Arbeit wurde bisher 3-mal zitiert (Crossref) und nennt 61 Literaturangaben. Gefördert von: PI award, Science Foundation Ireland for their SFI AI for Good Challenge, Disruptive Technology Innovation.
Abstract (Originalsprache)
Purpose
Multiple Sclerosis is an inflammatory neurodegenerative disease characterised by blood‐brain barrier dysfunction and leukocyte infiltration into the CNS. Platelets are best known for their contributions to haemostasis, however, upon activation, platelets release an abundance of soluble and vesicular‐associated proteins, termed the platelet releasate (PR). This milieu contains numerous inflammatory and vasoactive proteins, that can attract leukocytes and alter endothelial permeability. Experimental design We aimed to characterise the PR of Relapsing‐Remitting multiple sclerosis (RRMS) patients, previously characterized regarding thrombin generation dynamics compared to healthy controls. We carried out LFQ proteomic profiling of the PR from 15 RRMS and 19 aged‐matched healthy controls.
Results
We identified 9 proteins increased and 16 proteins decreased in the PR of RRMS patients. Platelet/endothelial cell‐adhesion molecule‐1 (PECAM‐1) was uniquely found in healthy control PR and circulating levels of PECAM‐1 were significantly lower in RRMS patient samples. GO analysis revealed a strong link between altered proteins and extracellular vesicles (EVs). Small EV levels were significantly reduced in RRMS PR compared to healthy PR and showed a negative correlation with PECAM‐1 levels in RRMS plasma. Conclusions and clinical relevance Our findings suggest that platelet reactivity may be linked to disease activity, even in periods of disease remission.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- SPHERE Research Group, Conway Institute, University College Dublin, Dublin, Ireland.
- School of Biomolecular and Biomedical Science, University College Dublin, Dublin, Ireland.
- Department of Neurology, Tallaght, University Hospital, Dublin, Ireland.
- School of Medicine, Trinity College Dublin, Dublin, Ireland.
- Department of Haematology, Rotunda Hospital, Dublin, Ireland.
- Department of Haematology, Mater Misericordiae University Hospital, Dublin, Ireland.
Förderung
- PI award
- Science Foundation Ireland for their SFI AI for Good Challenge
- Disruptive Technology Innovation
Zitieren
APA
Parsons, M., O'Connell, K., Szklanna, P., Weiss, L., Kenny, M., Donnelly, A., Norris, J., Babyuk, Y., O'Donoghue, L., Ní Áinle, F., McGuigan, C., & Maguire, P. B. (2025). Characterisation of Platelet Releasate Proteome in Relapsing‐Remitting Multiple Sclerosis Reveals Dysregulation of Inflammatory Signalling and Extracellular Vesicle Dynamics. PROTEOMICS – Clinical Applications. https://doi.org/10.1002/prca.202400019
Vancouver
Parsons M, O'Connell K, Szklanna P, Weiss L, Kenny M, Donnelly A, et al. Characterisation of Platelet Releasate Proteome in Relapsing‐Remitting Multiple Sclerosis Reveals Dysregulation of Inflammatory Signalling and Extracellular Vesicle Dynamics. PROTEOMICS – Clinical Applications. 2025. doi:10.1002/prca.202400019
BibTeX
@article{Parsons2025,
author = {Parsons, Martin and O'Connell, Karen and Szklanna, Paulina and Weiss, Luisa and Kenny, Martin and Donnelly, Aisling and Norris, Jessica and Babyuk, Yuri and O'Donoghue, Lorna and Ní Áinle, Fionnuala and McGuigan, Christopher and Maguire, Patricia B},
title = {Characterisation of Platelet Releasate Proteome in Relapsing‐Remitting Multiple Sclerosis Reveals Dysregulation of Inflammatory Signalling and Extracellular Vesicle Dynamics},
journal = {PROTEOMICS – Clinical Applications},
year = {2025},
doi = {10.1002/prca.202400019}
}
EUVIMED